Transforming growth factor-beta1 shows an incremental osteoinductive dose-response relationship.

Autor: Moxham JP; Department of Surgery, University of British Columbia, Vancouver, Canada. pmoxham@cw.bc.ca, Wong KK, Kibblewhite DJ
Jazyk: angličtina
Zdroj: The Laryngoscope [Laryngoscope] 2009 Jan; Vol. 119 (1), pp. 126-30.
DOI: 10.1002/lary.20009
Abstrakt: Objective: To determine if there is a dose-response curve for TGF-beta1 in a rabbit calvarial defect model.
Study Design: Controlled animal study using arms of increasing concentrations of TGF-beta1 to evaluate the osteoinductive potential of each arm.
Methods: Sixteen skeletally mature New Zealand white rabbits were randomized into control and experimental arms. Incremental doses of TGF-beta1 delivered in an inactivated guanidine-extracted demineralized bone matrix (Gu-DBM) carrier were implanted into a critically sized calvarial defect. The animals were sacrificed at 4 weeks and histomorphometric analysis was then accomplished.
Results: TGF-beta1 showed a dose-response relationship, with the higher doses chosen for this study causing more robust osteoinduction.
Conclusions: In this pilot dosing study, TGF-beta1 demonstrates increasing osteoinduction with increasing dose levels in this animal model.
Databáze: MEDLINE
Externí odkaz: